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Abstract
Background:  As stigma is a socially constructed concept, it would follow that stigma related to sexual
behaviours and sexually transmitted infections would carry with it many of the gender-based morals that are
entrenched in social constructs of sexuality. In many societies, women tend to be judged more harshly with
respect to sexual morals, and would therefore have a different experience of stigma related to sexual behaviours
as compared to men. While a variety of stigma scales exist for sexually transmitted infections (STIs) in general;
none incorporate these female-specific aspects. The objective of this study was to develop a scale to measure the
unique experience of STI-related stigma among women.
Methods: A pool of items was identified from qualitative and quantitative literature on sexual behaviour and STIs
among women. Women attending a social evening program at a local community health clinic in a low-income
neighbourhood with high prevalence of substance use were passively recruited to take part in a cross-sectional
structured interview, including questions on sexual behaviour, sexual health and STI-related stigma. Exploratory
factor analysis was used to identify stigma scales, and descriptive statistics were used to assess the associations
of demographics, sexual and drug-related risk behaviours with the emerging scales.
Results: Three scales emerged from exploratory factor analysis – female-specific moral stigma, social stigma
(judgement by others) and internal stigma (self-judgement) – with alpha co-efficients of 0.737, 0.705 and 0.729,
respectively. In this population of women, internal stigma and social stigma carried higher scores than female-
specific moral stigma. Aboriginal ethnicity was associated with higher internal and female-specific moral stigma
scores, while older age (>30 years) was associated with higher female-specific moral stigma scores.
Conclusion: Descriptive statistics indicated an important influence of culture and age on specific types of stigma.
Quantitative researchers examining STI-stigma should consider incorporating these female-specific factors in
order to tailor scales for women.
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Background
Stigma has long been a part of our social existence, with
the original Greek translation referring to a physical sign
exposing a moral imperfection[1]. While in today's soci-
ety the physical mark need not be present, the moral asso-
ciations have remained intact. The topic of sexually
transmitted infections (STIs) presents a good example of
the dynamic and socially fluid nature of stigma, as
opposed to the stationary, objectified definition it is
sometimes given [2]. In relation to the categories of
stigma outlined in Goffman's (1963) foundational work,
STIs could be argued to cross all three – stigma of the
body, of moral character and of tribe[1,3]. In addition, for
any one individual, STIs could also blur the boundaries of
the discredited – one who is overtly stigmatized – and the
discreditable – one who may be able to conceal their stig-
matizing feature – depending on the nature of social inter-
action at any particular time[1,4].
Sexual morals have typically had a gender imbalance,
leading to a stronger social stigmatization of women.
Many societies and cultures view promiscuity among men
favourably (e.g., as a measure of virility or status), while
promiscuity among women is viewed as undesirable and
immoral [3,5,6]. In the late 19th and early 20th centuries,
the social and medical standpoints on the spread and pre-
vention of STIs were influenced strongly by these gender
stereotypes. For example, in World War I, STI prevention
flyers were used to warn soldiers away from the 'dirty'
women who would infect them with STIs, which they
might then pass on to their 'good' wives [7]. Prior to avail-
able treatment, the impact of STI sequelae was so great
among soldiers, some states enacted laws against 'promis-
cuity', and many single women were arrested or detained
for such things as being out at a bar or club on their own
[7]. Today's views on sexual behaviours and STIs may not
be as overtly imbalanced, but there remains an underlying
gender bias in the stereotypes and the meanings associ-
ated with STIs, resulting in different stigma experiences
and generally higher negative impacts among women
[8,9].
The continued impact of the good/bad dichotomy on
women's perceptions of STIs is captured in the qualitative
work of Nack (2002)[3]. In her work, discourse evolved
around sexual behaviour norms and behaviour that was
deemed appropriate for women evolved around the
moral division of respectable or 'good girls' and disrepu-
table or 'bad girls', leading to the development of the idea
of 'tribes of womanhood'. Membership in the 'good girl
tribe' or morally-correct category, whether through actual
behaviour, avoidance of STI or concealment of behaviours
or diagnoses, was precarious, while membership in the
'bad girl tribe', was easy to gain and often thought of as
irreversible.
In addition to the potential psychological harms an indi-
vidual might deal with when faced with a positive STI test
result, there may also be an impact on testing and treat-
ment behaviours at the population level. In part, this may
be explained by the additional STI-related stigma that can
arise within health care settings (e.g., patients must reveal
the relevant details of their sexual behaviour in order to
seek help from caregivers, thereby risking becoming dis-
credited; patients may also fear being discredited to other
clinic staff who may have access to their charts). Patient
comfort, appropriate staff communication, confidential-
ity and respect for the feelings of the women have been
identified as key stigma-related factors that need to be
addressed in the provision of STI services[10]. A similar
study in the southern U.S. outlined four important con-
cepts of stigma that surfaced from qualitative focus
groups, including religious ideation of health care workers
affecting their views of 'promiscuous' women, privacy
fears among men, racial attitudes and stigma transference
or fear of being labelled [11]. Thus, the ability to present
safely and comfortably in a clinic setting can be disturbed
by actual or perceived discriminating attitudes of the
other clinic attendees, the doctors and nurses, or other
clinic staff.
Stigma scales exist for general disabilities, mental health,
and more recently for HIV/AIDS [12-15]. There are, how-
ever, few scales that examine stigma in relation to STIs
(notably, Fortenberry's stigma and shame scales[16,17])
and none that incorporate female stereotypes related to
sexual morals, as well as the perceptions of both the com-
munity in general and health care professionals in partic-
ular. The purpose of this study was to develop a stigma
scale specific to women, which encompassed a broader
range of the stigma experience associated with sexuality
and STIs. The present paper outlines the preliminary
development of such a scale, and assesses the demo-
graphic and behavioural characteristics associated with
the resulting scales.
Methods
An interviewer-administered structured survey was carried
out among 126 women attending a weekly program
exclusive to women (including transgendered individu-
als) held at a local community health clinic in Vancou-
ver's Downtown Eastside. This region is
disproportionately impacted by issues including sub-
stance use, mental illness, homelessness and poverty.
Compared to the rest of the province, census data from
2006 indicated higher levels of income assistance (4.1%
vs. 0.6%), higher levels of low income households
(23.9% vs. 12% of families earning < $20,000 CDN), and
inferior health outcomes (life expectancy at birth 75 vs 81
years)[18]. Due to the concentration of injection drug use
and sex work in this high risk neighbourhood, the regionBMC Women's Health 2008, 8:21 http://www.biomedcentral.com/1472-6874/8/21
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also exhibits high prevalence of HIV and other STIs[19-
21].
The women's program is open to all women, and sees any-
where from 20 to 60 women in one evening (for more
detailed information on the program and population, see
Rusch, et al. 2008 [22]). The weekly, three-hour program
offers women a safe place to access food and health care,
as well as to socialize with other women, and take part in
various activities including free haircuts, foot baths, art
projects, and movie nights. There is also access to doctors
and nurses, counselling services and massage therapy. The
program is advertised through fliers at the clinic and other
community organizations frequented by women. Women
were passively recruited through an announcement at the
start of each evening inviting women to take part in the
study. Although there was no overt advertising for the
study, snowball sampling through word-of-mouth was
used to recruit women, including those women who may
not have been accessing the evening program on a regular
basis.
The 27-item structured interview was used to gather data
to describe the socio-demographic characteristics of the
study participants, their use of and contact with services
available in their community (including their contact
with outreach programs, outreach workers and street
nurses), as well as their self-reported patterns of sexual
behaviour and drug use. We also asked questions about
their use of sexual health care services such as annual pap
smears and testing or treatment for STIs. The purpose of
the larger study was to determine the characteristics and
risk levels of the women attending the program in order
to help inform program planners and to help tailor out-
reach initiatives for those women missing from the demo-
graphic, as well as to assess potential barriers to sexual
health care among this population of women.
Participants were given a copy of the consent form, and
study coordinators read through the details of participa-
tion before asking for their consent. Regular clinic staff
and doctors were not actively involved in the recruitment
or interviewing, and the consent included a statement
reassuring participants that if they chose not to partici-
pate, there would be no consequences to their involve-
ment with the clinic or the women's night program, nor
their normal receipt of care at the clinic. As part of the
larger study, participants had the option of providing a
urine sample for Chlamydia and gonorrhoea screening;
however, this was not a requirement for taking part in the
study. The clinic provided follow-up care for participants
testing positive. Participants received $10 remuneration
for completing the structured interview. This study was
approved by the University of British Columbia Behav-
ioural Ethics Review Board.
While transgendered individuals were not excluded from
participating in the study, they were not included in the
present analysis, as STI-stigma perceptions may be very
different in this population and there were insufficient
numbers (N = 4) to allow for comparison.
An 18-item pool was created building on Goffman's
(1963) basic three categories, drawing on previous con-
structs from a general STI stigma and shame scale by
Fortenberry et al (2002), and incorporating the idea of the
tribes of womanhood introduced by Nack
(2002)[1,3,17]. In addition, based on other discourse
around stigma and sexual health care seeking behaviours,
items relating to Goffman's category of 'moral' stigma
included both internal feelings of guilt or shame, as well
as the perceived views of others in the community, includ-
ing health care workers and intimate partners [10,23].
Items were also included to encompass concerns over dis-
cretion, confidentiality and gossip. While the items were
developed and selected based on the pre-existing theories
and literature mentioned above, the analysis was explora-
tory rather than theory-driven and therefore did not pre-
suppose any categories or groupings of the items.
Items were assessed for endorsement using a discrimina-
tion index, and for internal consistency within subgroups
using Pearson's correlations. Problematic items were
highlighted and taken into account during exploratory
factor analysis.
Exploratory principal component factor analysis was
done using promax (oblique) rotation to explore the cat-
egories present in the responses. An iterative process was
used, discarding one item at a time based on factor load-
ings as well as on discretion and internal consistency
results, where applicable. From the original 18 items, four
were discarded due to poor discrimination or poor factor
loading. For each of the remaining 14 items, non-
responders were compared to responders in order to
assess variability.
For the three resulting scales (female-specific moral
stigma, social stigma and internal stigma), item-total cor-
relation and alpha scores were calculated. Means and
standard deviations are also presented. Associations of the
three final scales with demographic and behavioural char-
acteristics were assessed using the Wilcoxon rank-sum
test.
Results
Demographics of the 126 participants are shown in Table
1. The median age was 42 years, approximately 40% iden-
tified as Aboriginal, Inuit or Métis, and approximately
40% reported having completed high school. Unemploy-
ment was high (95%), as was substance use (injectionBMC Women's Health 2008, 8:21 http://www.biomedcentral.com/1472-6874/8/21
Page 4 of 10
(page number not for citation purposes)
drugs: 40%, non-injection drugs: 80%). Thirty-eight per-
cent of the women were currently involved in sex trade.
Table 2 outlines the STI-related stigma items included in
the structured interview. Items included feeling dirty, feel-
ing violated, knowing (and conversely, not knowing) that
an STI was present, being able to hide an STI from others,
feeling guilty, feeling embarrassed, perceiving those with
an STI as having low intelligence, bad character and spe-
cifically, bad character as judged by clinic staff. Four items
incorporated concepts introduced by Nack (2000, 2002)
elucidating what women perceived to be the "type of
woman" who gets an STI: 1) being 'damaged goods', 2)
being promiscuous, 3) being at fault as "women should
'know better"' and 4) being at fault for not being "careful
enough"[3,4]. Lastly, four items were included to encom-
pass discretion of clinic setting and clinic staff, concern
regarding community gossip, and fear of repercussions
from partner disclosure. It was felt that including items
regarding discretion and disclosure would build on the
concept of social judgement, potentially allowing a subtle
distinction between women who perceived others to be
judgemental and women who were concerned about
being judged, or becoming, even in a hypothetical setting,
discredited.
Using the discrimination index, four items were flagged,
including items 4 and 6 (being able to hide an STI and not
knowing an STI was present), item 10 (staff discretion)
and item 16 (staff morals). Using p < 0.20 as the cut-point
for internal consistency, another two items were initially
flagged, including item 3 (knowing an STI was present)
and item 17 (partner disclosure). Internal consistency was
also re-evaluated within the sub-groups emerging during
exploratory analysis.
Principal component factor analysis using all items was
first assessed, and the resulting eigenvalues were plotted,
revealing three distinct factors arising from the item pool.
Iterative factor analysis was done, omitting items one at a
time. Item 4 and 17 were the first two deleted, as their fac-
tor loadings were low and both had been flagged as hav-
ing low discrimination or internal consistency. Item 6 was
then deleted, due to multiple factor loading, low discrim-
ination and consistency. Finally, item 3 was dropped, as it
continued to load poorly and had low internal consist-
ency. Correlation between the final three factors (factors 1
and 2: -0.18; factors 1 and 3: 0.23; factors 2 and 3: -0.21)
was not high enough to warrant combining the three sub-
scales into one larger scale.
The remaining 14-items factored together in three final
scales – female-specific moral stigma, social stigma and
internal stigma – shown in Table 3. The four items that
factored together in the first scale were derived from the
work by Nack[3,4], surrounding the 'tribes of woman-
hood' and included moral judgement statements typically
imposed on women as opposed to men, resulting in the
name 'female-specific moral stigma'. All the items that fac-
tored together in the second scale referred to how the par-
ticipants felt others perceived someone with an STI,
prompting the name 'social stigma'. Finally, both moral
and physical stigma items factored together in the third
scale; however, in examining the wording of these items,
all four were directed at how participants would feel about
themselves if they were diagnosed with an STI, thus
prompting the name 'internal stigma'.
In Table 3, item-total item correlations and alpha co-effi-
cients if deleted for the three emergent factors are shown,
Table 1: Demographics of 126 participants attending a women's 
program in a community clinic located in a low-income, high risk 
neighbourhood
Total
(N = 126)
Gender
Female 96.8 (122)
Transgender 3.2 (4)
Median age (IQR) 42 (36, 49)
Ethnicity
White 52.4 (66)
Aboriginal 39.7 (51)
Education
<High school 59.5 (75)
High school 40.5 (51)
Employment
Any 5.6 (7)
None 94.4 (119)
Drug Use
Injection 39.7 (48)
Non-injection 81.8 (99)
Alcohol 41.6 (52)
Sexual partners (past 6 mos)
Regular partner 57.9 (73)
Casual partner 20.6 (26)
>1 partner 45.6 (57)
Commercial Sex Work status
Non- 30.2 (38)
Former 26.2 (33)
Current 38.1 (48)
Attendance at Weekly Women's Program
Never 23.8 (30)
Sometimes/Regularly 76.2 (96)BMC Women's Health 2008, 8:21 http://www.biomedcentral.com/1472-6874/8/21
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along with scale statistics and cronbach's alpha. The alpha
co-efficients for each scale were 0.737, 0.705 and 0.729
for female-specific moral stigma, social stigma and inter-
nal stigma, respectively. It is possible that two of the items
(items #9 and #10) addressing women's perceptions of
staff and clinic discretion may be measuring characteris-
tics of this particular clinic, rather than of women's gen-
eral perceptions, and may not be warranted in a stigma
scale for wider use. Thus, an alternative analysis was run
eliminating these items. The results were identical, with
the exception of the social stigma scale, which now con-
sisted of only four items and had a Cronbach's alpha score
of 0.647.
Assessing each item for response and non-response char-
acteristics, there was no large variation found; however,
overall injection drug users and current sex workers were
less likely to complete the stigma section of the question-
naire. As the stigma-related items were positioned at the
end of the 27-item structured interview, a few women did
not complete all of the questions and nine women were
excluded due to incomplete answers in the stigma section
of the structured interview. However, subsequent to the
factor analysis and determination that the three scales did
not correlate sufficiently to combine into one large scale,
women who answered at least all of the stigma items rep-
resented in any one scale were included in the final calcu-
lation of Cronbach's alpha-scores shown in Table 3.
In Table 4, the associations of demographic and behav-
ioural characteristics with the three stigma scales are
shown. Higher female-specific moral stigma scores were
marginally associated with being over 30 years of age,
identifying as Aboriginal, Inuit or Métis and not reporting
any use of injection drugs in the past six months. Among
active CSW, higher social stigma scores were associated
with having been working in the sex trade for less than 10
years, while among all the women, there was a marginal
association of higher social stigma among women who
did not report use of any non-injection drugs in the past
six months. Higher internal stigma scores were associated
with not having completed high school and identifying as
Table 2: Items developed for STI-related stigma scale, measured on a 10-point scale (1 = strongly disagree, 10 = strongly agree)
If you had an STI, you would feel: Mean (std) Median (IQR)
1. Dirty 7.11 (3.42) 8 (5, 10)
2. Violated 7.58 (3.24) 10 (5.5, 10)
Someone with an STI:
3. Would know it 5.72 (3.71) 5.5 (1, 10)
4. Could hide it 7.13 (3.31) 9 (5.5, 10)
5. Is damaged goods 3.25 (3.10) 1 (1, 5.5)
6. May not know 8.04 (2.99) 10 (6, 10)
If you had an STI, you would feel:
7. Guilty 5.46 (3.88) 5.5 (1, 10)
8. Embarrassed 6.25 (3.86) 8 (1, 10)
At the clinic:
9. Everyone would know if you were being tested for an STI 2.43 (2.82) 1 (1, 2)
10. Staff are discreet 9.43 (1.62) 10 (10, 10)
(Only) women .......... get STIs:
11. Who have slept around 2.94 (3.09) 1 (1, 5.5)
12. Should know better than 4.69 (3.73) 3 (1, 9)
13. Who aren't careful 4.19 (3.58) 3 (1, 7)
If someone has an STI:
14. People will think she is a bad person 4.27 (3.28) 3.5 (1, 6)
15. People will gossip 5.31 (3.41) 5.5 (1, 8)
16. Health workers will think poorly of her 2.86 (2.74) 1 (1, 5.5)
If you had an STI:
17. Your partner would be angry with you
7.28 (3.47) 10 (5, 10)
If someone has an STI:
18. People will think she is stupid
3.58 (3.04) 1.75 (1, 5.5)BMC Women's Health 2008, 8:21 http://www.biomedcentral.com/1472-6874/8/21
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Aboriginal, Inuit or Métis ethnicity. In a multivariable lin-
ear regression model, Aboriginal ethnicity (β = -1.63; p =
0.002) and less than a high school education (β = -1.27; p
= 0.010) remained significantly associated with internal
stigma score, adjusting for age, commercial sex work and
injection drug use (N = 110, R-squared = 0.180). There
were no significant associations in multivariable models
for either the female-specific moral stigma or social stigma
scales.
Discussion and Conclusion
While qualitative studies can help us develop a deeper
understanding of women's experiences of stigma; quanti-
tative measures can be useful for comparing the magni-
tude and prevalence of stigma-related experiences across
or within populations. In this paper, three distinct STI-
related stigma scales emerged from a pool of items
addressing STI issues including physical stigma, moral
stigma, judgment by community and by healthcare work-
ers in particular, as well as female-specific sexual categori-
zations of 'good' and 'bad' girls. The resulting female-
specific moral stigma scale was not found to be signifi-
cantly different among participants; however, there were
marginally higher scores among Aboriginal women, IDUs
and women with lower education levels. Social stigma
was found to be higher among more recent initiates into
the sex trade, while internal stigma was higher among
those with lower education as well as among women
reporting Aboriginal, Inuit or Métis ethnicity.
The perception of any stigma will invariably be affected by
both the previous experiences of an individual as well as
their current situation. Nack (2002) found that women
who had higher perceptions of stigma prior to their own
experiences with STIs (being tested and/or testing posi-
tive) and those women who identified as 'good' girls were
more affected by the notion of being identified as a 'bad
girl' [3]. Others who had previously received education
about STIs as well as those who felt they already belonged
in the 'bad' girl category were less concerned with these
female-specific moral categories and social forms of
stigma. In our study, while female-specific moral and
social stigma did not vary significantly by demographic or
behavioural characteristics, those with higher female-spe-
cific moral stigma scores were less likely to be active injec-
tion drug users.
In contrast, those women in our study with higher social
stigma scores were less likely to be active non-injection
drug users, and, among active sex workers, were more
likely to have been working for less than 10 years. This
may reflect an 'accommodating' phenomenon whereby
women who already view themselves as 'bad' girls (i.e.
active drug users, highly active sex workers) are less con-
cerned with societal views and stigma. Societal norms,
Table 3: Item-total item correlation and alpha-coefficients if deleted and scale statistics for three factors identified in factor analysis
Item Factor 1:
Female-specific Moral Stigma
Factor 2:
Social Stigma
Factor 3:
Internal stigma
r(i-t) α(d) r(i-t) α(d) r(i-t) α(d)
1. Dirty 0.547 0.652
2. Violated 0.457 0.703
5. Damaged goods 0.459 0.719
7. Guilty 0.473 0.692
8. Embarrassed 0.591 0.623
9. Clinic discretion* 0.432 0.667
10. Staff discretion* 0.413 0.673
11. Sleeps around 0.598 0.632
12. Should know better 0.563 0.658
13. Isn't careful 0.478 0.697
14. Bad person 0.398 0.676
15. Community gossip 0.443 0.664
16. Staff morals 0.519 0.639
18. Stupid 0.404 0.675
N 120 116 122
Alpha Co-efficient 0.737 0.705 0.729
Mean 3.77 5.16 6.59
SD 2.52 1.81 2.68
*As these items may refer to perceptions of a specific clinic, an alternative Cronbach's alpha score for the social stigma scale, eliminating these two 
items would be 0.647; other factors were not affected by removal of these items. Note: item 10 score was reversed for factor analysis.BMC Women's Health 2008, 8:21 http://www.biomedcentral.com/1472-6874/8/21
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Table 4: Characteristics associated with standardized scales for female-specific moral stigma, social stigma and internal stigma, with 
higher scores indicating higher stigma
Female-specific Moral Stigma Social Stigma Internal Stigma
N Median p-value Median p-value Median p-value
Demographics
Age > 30
≤ 30
111
10
3.25
2.12
0.085† 4.00
3.50
0.536 5.37
6.75
0.813
High School (HS)
No HS
50
73
3.37
3.25
0.928 3.37
4.00
0.464 5.50
7.50
0.008*
Aboriginial, Inuit, Metis
Other
49
74
4.37
3.25
0.072 † 3.50
4.12
0.340 7.75
5.50
0.001*
Substance Use
Injection Drug use
No IDU
45
73
3.00
3.62
0.076 † 3.37
4.00
0.584 6.50
7.25
0.960
Non-Injection Drug use
No NIDU
96
22
3.25
4.75
0.216 3.25
4.56
0.061 † 7.19
5.50
0.346
High Alcohol
(> 6 drinks, >1 a week)
Low Alcohol
11
109
3.62
4.00
0.916 4.75
3.50
0.743 7.25
8.87
0.150
Sexual Behaviour
Any partner
No partner
96
27
3.25
3.25
0.435 3.75
4.00
0.628 6.69
5.62
0.643
Regular partner
No regular partner
72
24
3.25
3.25
0.570 4.25
3.25
0.164 7.37
5.50
0.292
Casual partner
No casual partner
25
71
3.25
3.25
0.418 3.25
4.00
0.773 6.00
6.62
0.880
> 1 partner (non-client)
≤ 1 partner
25
69
3.37
3.25
0.185 4.00
4.00
0.614 7.12
6.25
0.702
CSW – Never
Former
Current
38
33
46
3.37
3.00
3.25
0.816 4.31
3.25
3.50
0.178 5.56
7.37
6.69
0.841
Among active CSW:
Years working
≥ 10 years
<10 years
29
19
3.00
3.25
0.864 3.25
5.00
0.007* 6.62
6.75
0.891
Clients (past 6 mos)
≥ 50 clients
< 50 clients
33
13
2.25
3.25
0.592 3.25
4.00
0.427 5.50
7.50
0.611
STI Communication
With Partner – Yes 91 3.25 0.275 3.50 0.467 6.50 0.485
No 31 4.37 4.00 6.62
With Friend – Yes 74 3.25 0.926 3.37 0.594 6.00 0.497
No 48 3.37 4.37 7.00
With HC worker – Yes 110 3.25 0.640 4.00 0.705 6.66 0.966
No 12 2.50 3.25 6.12
*p < 0.05; † p < 0.10BMC Women's Health 2008, 8:21 http://www.biomedcentral.com/1472-6874/8/21
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which are intrinsically tied to the social constructions of
stigma, thus play a powerful role in self-identity and cate-
gorization into these predefined groups. The impact is
even greater among marginalised communities, who are
already separated from 'mainstream' society, generally
due to a combination of factors including poverty, ethnic-
ity, or other non-conforming behaviours (substance use,
sex work). Within a marginalised community, the concept
of female-specific moral stigma may serve to deepen the
divide between women who are identified or self-identify
as 'bad' girls, and those who self-identify as 'good' girls
but who feel potentially labelled incorrectly because of
their affiliation with the larger community. This may
engender an intensified stigma between these groups in
an effort to explicitly remove the 'community' level stigma
from individual 'good' girls within the community.
High levels of female-specific moral stigma and internal
stigma were found among Aboriginal women in our
study. Given that minority women have historically been
singled out as 'vectors and vessels' of STI transmission, the
higher STI-stigma scores among Aboriginal women may
represent a compounding of cultural stigma felt by these
women [24-26]. And, while public health and research
efforts (e.g., targeted testing and treatment of Aboriginal
women in the community; numerous studies that report
very high rates of HIV and STIs in this population) are
meant to assist this population in accessing testing, it is
possible that Aboriginal women in our study feel 'cultur-
ally targeted' – resulting in high levels of stigma and STI-
stigma in particular.
Aside from this, there are other cultural factors which may
be influencing the way in which the stigma scale is inter-
preted. The traditional meanings of female sexual moral-
ity in Aboriginal cultures may shape the way these specific
stigma items, most which reflect a Western definition of
feminine morality rooted in Christianity, are felt. For
example, in many Aboriginal cultures, sex and sexuality
are taught as being a gift, although a powerful one which
needs to be respected[27]. The central idea of balance and
the holistic views of health are also important and theo-
retically cultivate a healthy view of sexuality, as opposed
to Western views which tend to stress the association
between sexuality and sin[27]. In addition, in matrilineal
clans female gender did not reflect lower status, and many
ancient stories venerated strong, powerful female fig-
ures[28]. Despite these traditional meanings, the rise of
residential schools which removed Aboriginal children
from their families in order to 'educate' them in Western
and Christian ways, introduced, or forced, these ways of
thinking onto their existing cultures. This, coupled with
Western perceptions of Aboriginal women as either "the
glorified 'princess' or the denigrated 'squaw"'[28], make it
difficult to predict how this entangled history may influ-
ence the present interpretation of stigma items. Neverthe-
less, the increased internal stigma seen in this study
among Aboriginal women remained in a regression
model controlling for age, education, injection drug use
and sex work status indicating that a culturally-specific
influence was present.
Unfortunately, it is difficult to tease out the historically
gendered and socially moral underpinnings of sexuality
from sexual and sexual health education. We may be more
aware today of the double-standards that exist in society's
view of how men and women should  behave sexually;
however, there remains an ingrained social double-stand-
ard which can, consciously or subconsciously, alter one's
perceptions even among those who do not prescribe to
these views. An example of this was reported by Nack
(2000), where women diagnosed with an STI described
their diagnosis as either 'deserved' or 'undeserved' based
on their perceptions of what society viewed as acceptable
behaviour and how this fit in with their own past histo-
ries[4]. In the present study, the items making up the
female-specific moral stigma scale included statements
with a moral tone placing the responsibility, or insinuat-
ing the fault, of STIs on women. Although the responses
were skewed towards low stigma levels, a quarter of the
women had moderate to high overall agreement with
these items.
There are several limitations to this study. First, as the
stigma scales were developed as a preliminary analysis of
perceptions in this population of women, there was no
inclusion of an external tool for validation. In this partic-
ular setting, it was felt that including several scales for this
purpose would unduly increase respondent burden. Sec-
ond, the sample was a convenience sample of women
already connected with community services – therefore,
we cannot generalize findings to the broader community
of women in this area who may not be accessing services
in any capacity. In addition, the scale categories (female-
specific moral stigma, internal stigma, social stigma) that
emerged from this exploratory analysis should be tested in
a larger population using an hypothesis driven factor
analysis (i.e. comparing the pre-supposed categories to
the data). Thus, the present scales, while providing valua-
ble insight, should undergo further development and test-
ing to assess its usefulness on a larger scale. This is also
true as the study sample size presents a limitation with
respect to the ability to detect differences of less than 2.0
units in the scale scores. It is difficult to say whether the
marginal results seen with differences of only 1.0 unit
would become significant in a larger sample; however, the
potential implications of these differences are presented
and discussed as theories requiring further evaluation.BMC Women's Health 2008, 8:21 http://www.biomedcentral.com/1472-6874/8/21
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With few significant differences in stigma scores among
sub-groups of women, the question of the practical use of
such scales arises. Comparisons beyond demographics
and behaviors, such as contact with health care providers,
access of testing and treatment programs would provide a
better picture of how these stigma measures may influ-
ence sexual health. Further, although the findings pre-
sented here lacked sufficient power to detect smaller
differences, the suggested increased levels of female-spe-
cific moral stigma, social stigma and internal stigma
among sub-groups of women is theoretically plausible
and should be further evaluated in a larger population. As
mentioned above, the presence of cultural differences
indicates the necessary evaluation of the potentially differ-
ent meanings and interpretations of STI-stigma, female
sexual morals, and social perceptions held by different
cultures. Importantly, the interpretations given here can
only be seen as suppositions, and are limited by the lack
of a priori investigation into these cultural influences and
meanings.
A final limitation is that the current study only sampled
women. While we developed our female-specific items
from an extensive literature outlining the unique sexual
categorization of women, we did not directly compare the
endorsement of the items among women to similar items
among men. Of note, STIs and barriers to care, including
STI-related stigma, are just as important among men, and
while the measure may be very different, scales that assess
these experiences among men should also be developed.
The study was nevertheless able to sample a diverse group
of women from a high-risk neighbourhood. In addition,
while the sample was recruited from a clinic site, the
evening program serves as a drop in for many services,
including dinner, clothing and other aspects not directly
related to seeing a health care professional. Despite the
neutral setting of the evening, it is a clinic and, even within
the context of a safe evening for women, perceptions of
STI-related stigma and moral categories of 'bad' versus
'good' girls were recorded.
As public health practitioners continue to work to prevent
and reduce the impact of STIs in highly marginalised pop-
ulations, it will be important to consider the roles of STI-
related stigma. Prevention or screening programs that are
'tailored' (rather than 'targeted') for particular high-risk
groups may be less likely to add to perceptions of discrim-
ination or stigma. In addition, in highly marginalised
communities, where the population at risk represents a
broad group of women, the preconceived notions of 'bad
girl' membership may supersede participation in other-
wise beneficial programs (e.g., a more general women's
program may draw participation from a certain group of
women, such as non-sex workers, creating an environ-
ment that is less desirable for another group, such as
active sex workers). Thus, in the creation of new sexual
health interventions and prevention messages, particular
attention should be paid to the language used and the
potentially subtle ways in which programs may isolate
rather than integrate members of the community. For
example, messages that highlight good sexual health prac-
tices and the benefits of treatment, rather than those that
advertise the consequences of bad behaviour (and thereby
condemn those that practice them) could help encourage
individuals to seek sexual health care instead of avoiding
testing for fear of a potentially stigmatizing label. In addi-
tion, efforts to assess the importance of stigma as a barrier
to sexual health care should attempt to incorporate these
broader aspects of the stigma experience. Sexual stigma is
a deeply rooted construct in our society; however, this
should not be seen as an insurmountable barrier to creat-
ing programs and policies that work to change the damag-
ing and disproportionate impact of STI-related stigma on
women.
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